Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Other Non-Current Assets (2022 - 2023)

Universe Pharmaceuticals (UPC) has disclosed Other Non-Current Assets for 2 consecutive years, with $35864.0 as the latest value for Q3 2023.

  • Quarterly Other Non-Current Assets fell 98.53% to $35864.0 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $35864.0 through Sep 2023, down 98.53% year-over-year, with the annual reading at $35864.0 for FY2023, 98.53% down from the prior year.
  • Other Non-Current Assets hit $35864.0 in Q3 2023 for Universe Pharmaceuticals, down from $2.4 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $2.4 million in Q3 2022 to a low of $35864.0 in Q3 2023.